Paul B. Manning - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Paul B. Manning - trading volume in the past year for Candel Therapeutics, Inc.

Holdings reported by Paul B. Manning for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.21M $10.3M $4.67 Jun 25, 2025 By Paul B. Manning Revocable Trust
Common Stock 1.68M $8.09M $4.81 Jun 25, 2025 Direct
Common Stock 1.3M $6.27M $4.81 Jun 25, 2025 By BKB Growth Investments, LLC
Stock Option (Right to Buy) 14.2K Jun 17, 2025 Direct Common Stock

Transactions reported by Paul B. Manning for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.